Increasing Linkage to Family Planning Care for Individuals With Substance Use Disorder

Sponsor
Denver Health and Hospital Authority (Other)
Overall Status
Recruiting
CT.gov ID
NCT04162184
Collaborator
Department of Health and Human Services (U.S. Fed)
200
1
1
32.5
6.1

Study Details

Study Description

Brief Summary

This study will utilize mixed methods to develop and assess the feasibility and acceptability of a health educator intervention designed to connect patients in recovery from substance use disorder to reproductive health education and services.

Condition or Disease Intervention/Treatment Phase
  • Behavioral: Sexual Health Initiative for Navigation and Education (SHINE) Health Educator Intervention
N/A

Detailed Description

Developing effective reproductive health interventions for individuals in treatment for substance use disorder is an important public health priority. In the US nearly half (45%) of all pregnancies are unplanned and studies have consistently found this rate to be much higher among individuals in substance treatment, almost 90%. There is a paucity of research on interventions to support the family planning care of this population. The primary goal of this project is to identify an innovative delivery model to address the family planning needs of individuals of reproductive age in treatment for substance use disorder at an urban integrated safety-net health system. Through the use of mixed methods this study will address the following objectives: 1) To describe the family planning experiences and needs of individuals in treatment for substance use disorders (SUD) in a representative sample of patients and 2) To assess the feasibility and acceptability of the intervention among study participants. If found to be acceptable, efficacy should be assessed in a randomized controlled trial. A navigator model such as this is generalizable and could be easily integrated into a variety of settings.

Study Design

Study Type:
Interventional
Anticipated Enrollment :
200 participants
Allocation:
N/A
Intervention Model:
Single Group Assignment
Masking:
None (Open Label)
Primary Purpose:
Health Services Research
Official Title:
Increasing Linkage to Family Planning Care for Individuals With Substance Use Disorder
Actual Study Start Date :
Dec 16, 2019
Anticipated Primary Completion Date :
Jun 1, 2022
Anticipated Study Completion Date :
Sep 1, 2022

Arms and Interventions

Arm Intervention/Treatment
Other: Health Educator Intervention

As the population of focus in this study is diverse, including men and women regardless of pregnancy desire, the primary focus for the intervention for this study will be education, particularly for men. All participants that enroll in the study will be offered the intervention. The study health educator will use the PATH (Parenthood/Pregnancy Attitude, Timing, and How) framework questions to initially guide the conversation. Depending on the participant's desires, the educator will provide education on other topics such as sexually transmitted infections (STIs) and we will also navigate to clinical services as needed. The health educator will use a study manual to guide all intervention activities including engagement. Additionally, the health educator will collect data on intervention outreach, engagement, topics discussed, participant needs and outcomes.

Behavioral: Sexual Health Initiative for Navigation and Education (SHINE) Health Educator Intervention
a brief health educator-led behavioral intervention focused on educating, identifying reproductive health needs, and linking to services if desired
Other Names:
  • SHINE Intervention
  • Outcome Measures

    Primary Outcome Measures

    1. Intervention sessions completed. [up to 3 months]

      Intervention acceptability will be measured by the number of sessions completed by the health educator among participants enrolled in the study.

    2. Self-reported satisfaction with intervention. [up to 3 months]

      Intervention acceptability will be assessed by participant self-reported satisfaction with the intervention (via surveys) among those who complete the intervention sessions. Satisfaction will be assessed with 8 items on a 4-point scale describing how strongly participants agree with each statement. The response scale is coded so that a higher score reflects higher satisfaction and therefore a better outcome. Reported as mean overall score (range 1-32).

    Eligibility Criteria

    Criteria

    Ages Eligible for Study:
    18 Years to 44 Years
    Sexes Eligible for Study:
    All
    Accepts Healthy Volunteers:
    Yes
    Inclusion Criteria:
    • In treatment for substance use disorder at one of the participating clinics; 18-44 years of age; English-speaking; not currently pregnant; able to become pregnant (e.g., no history of hysterectomy, tubal ligation, hysterectomy, menopause); not planning to leave the Denver area in the next 3 months.
    Exclusion Criteria:
    • currently pregnant; intoxicated or mentally impaired to the point that one is unable to voluntarily consent to participate and/or respond to the surveys.

    Contacts and Locations

    Locations

    Site City State Country Postal Code
    1 Denver Health & Hospital Authority Denver Colorado United States 80204

    Sponsors and Collaborators

    • Denver Health and Hospital Authority
    • Department of Health and Human Services

    Investigators

    • Principal Investigator: Deborah Rinehart, PhD, MA, Denver Health & Hospital Authority

    Study Documents (Full-Text)

    None provided.

    More Information

    Publications

    None provided.
    Responsible Party:
    Deborah Rinehart, Research Scientist, Denver Health and Hospital Authority
    ClinicalTrials.gov Identifier:
    NCT04162184
    Other Study ID Numbers:
    • 19-2621
    • 1 FPRPA006064-01-00
    First Posted:
    Nov 14, 2019
    Last Update Posted:
    Apr 7, 2022
    Last Verified:
    Apr 1, 2022
    Individual Participant Data (IPD) Sharing Statement:
    Undecided
    Plan to Share IPD:
    Undecided
    Studies a U.S. FDA-regulated Drug Product:
    No
    Studies a U.S. FDA-regulated Device Product:
    No
    Keywords provided by Deborah Rinehart, Research Scientist, Denver Health and Hospital Authority
    Additional relevant MeSH terms:

    Study Results

    No Results Posted as of Apr 7, 2022